Gene editing could cure sickle cell by boosting fetal hemoglobin
⭐️ CURE ⭐️
Not yet recruiting
This pilot trial tests a gene-editing approach for sickle cell disease. Participants receive their own blood stem cells that have been edited to increase fetal hemoglobin, a healthy type of hemoglobin that prevents sickling. The goal is to cure the disease with a one-time treatme…
Phase: PHASE1 • Sponsor: Daniel Bauer • Aim: ⭐️ CURE ⭐️
Last updated Jul 18, 2026 00:00 UTC